2018
DOI: 10.1055/a-0641-5956
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Craniopharyngioma is a sellar/suprasellar benign tumor whose aggressiveness may imply in endocrine disturbances (hypothalamic obesity and hormone deficiencies). Fifty-seven patients were evaluated according to clinical characteristics, hypothalamic involvement, type of treatment, anthropometric variables, adiposity indexes (body mass index Z score category at diagnosis and post-treatment, total body fat, visceral adipose tissue, and metabolic syndrome components) and analyzed through multiple regression and lo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
1
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 39 publications
0
9
1
1
Order By: Relevance
“…This study also found that obesity at diagnosis was predictive of metabolic syndrome (OR, 6.1; P = .031). 23 Another study found overweight patients to have lower lean mass percentage on average (67.9%) than well-nourished (87.3%) or undernourished (84.1%) patients. 17 Three studies compared different anthropometric measurements to assess nutritional status in patients with several cancer diagnoses.…”
Section: Results By Primary Outcomementioning
confidence: 95%
See 3 more Smart Citations
“…This study also found that obesity at diagnosis was predictive of metabolic syndrome (OR, 6.1; P = .031). 23 Another study found overweight patients to have lower lean mass percentage on average (67.9%) than well-nourished (87.3%) or undernourished (84.1%) patients. 17 Three studies compared different anthropometric measurements to assess nutritional status in patients with several cancer diagnoses.…”
Section: Results By Primary Outcomementioning
confidence: 95%
“…Thirteen studies addressed nutritional status and body composition (Table 1). [14][15][16][17][18][19][20][21][22][23][24][25][26] Overall, the prevalence of underweight patients at diagnosis varied from 6% to 25% and during treatment from 10.5% to 52.4%. In patients with ALL, the most studied diagnosis, the prevalence of underweight varied from 6% to 21.2% at diagnosis, 19,[24][25][26] increasing to 52.6% in one study that assessed patients after at least one chemotherapy cycle.…”
Section: Results By Primary Outcomementioning
confidence: 99%
See 2 more Smart Citations
“…13,19,23,[39][40][41][42][43][44][45][46] Nos pacientes com LLA, diagnóstico mais estudado, a prevalência de subnutrição varia de 6 a 21,2% no momento do diagnóstico, 23,45,46 aumentando para 52,6% em um estudo que avaliou pacientes após pelo menos um ciclo quimioterápico. 41 Sobrepeso e obesidade possuem prevalências reportadas de 4,1 a 35% no diagnóstico, 13,[46][47][48] Os dados coletados abrangem peso, estatura e circunferência de braço de crianças e adolescentes com diagnóstico e/ou em tratamento oncológico. Além disso, foram coletados do prontuário médico a data de nascimento, diagnóstico, data de diagnóstico e data de óbito, quando pertinente.…”
Section: Cappesqunclassified